Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 12.80
+0.30 (2.40%)
Jul 16, 2026, 1:30 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 10.75 billion as of July 16, 2026. Its market cap has decreased by -64.68% in one year.
Market Cap
10.75B
Enterprise Value
11.97B
Revenue
69.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.80
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 10.75B, a decrease of -76.86%. That is a compound annual growth rate of -13.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 11.01B | -54.07% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACRO Biomedical | 16.10B |
| Medigen Vaccine Biologics | 15.58B |
| EirGenix | 15.33B |
| TCM Biotech International | 14.35B |
| Gongwin Biopharm Holdings | 12.73B |
| Tanvex BioPharma | 10.63B |
| AP Biosciences | 10.48B |
| PharmaEngine | 9.48B |